Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2026-05-04 @ 1:24 PM
Study NCT ID:
NCT05026866
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-17
First Post:
2021-08-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
Sponsor:
Organization: